Angle (AGL)

 

Latest News

Business Update

RNS Number: 9768D Angle PLC 03 May 2017 For immediate release 3 May 2017 ANGLE plc ("the Company") BUSINESS UPDATE HIGHLIGHTS PROGRESS WITH PARSORTIX LIQUID BIOPSY Ovarian cancer clinical studies progressing well with patient enrolment completed. Headline data on target for reporting this quarter MD Anderson Cancer Center signed...

Holding(s) in Company

RNS Number: 4527B Angle PLC 04 April 2017 For immediate release 4 April 2017 ANGLE plc ("the Company") Holding(s) in Company The Company has been informed by Lombard Odier Investment Managers group ("Lombard") that, following its recent acquisition of Henderson Volantis from Henderson Global plc ("Henderson"), Lombard has acquired ordina...

Parsortix enables analysis in head and neck cancer

RNS Number: 2731B Angle PLC 03 April 2017 For immediate release 3 April 2017 ANGLE plc ("the Company") PARSORTIX ENABLES GENE EXPRESSION ANALYSIS IN HEAD AND NECK CANCER Customer presents clinically relevant results at AACR 2017 with Parsortix where alternative approaches have failed University of Athens, Attikon University H...

Prostate Cancer Update

RNS Number: 9546A Angle PLC 30 March 2017 For immediate release 30 March 2017 ANGLE plc ("the Company") POTENTIAL FOR PREDICTION OF METASTASIS IN PROSTATE CANCER Barts Cancer Institute present new findings at World CDx Europe 2017 conference in London ANGLE plc (AIM:AGL OTCQX:ANPCY), the specialist medtech company, is...

All News

DateHeadlineSource
03-05-17Business UpdateRNS
04-04-17Holding(s) in CompanyRNS
03-04-17Parsortix enables analysis in head and neck cancerRNS
30-03-17Prostate Cancer UpdateRNS
13-02-17Selected for European Cancer ID ProgrammeRNS
26-01-17Interim Evaluation of Ovarian Cancer StudyRNS
26-01-17Interim ResultsRNS
06-01-17ANGLE Plc to present at the Growth and Innovation Forum 2017 in London on 31 January 2017StockMarketWire
04-01-17ANGLE schedules interims StockMarketWire
04-01-17Notice of ResultsRNS
29-12-16Our AIM tip soars 60% in 2016 Interactive Investor
28-11-16ISSUE OF SHARE OPTIONSRNS
24-11-16Result of GMRNS
04-11-16ANGLE welcomes new research supporting Parsortix StockMarketWire
04-11-16Barts Research Supports Potential Use of ParsortixRNS
01-11-16Notice of GMRNS
27-10-16Director's share purchaseRNS
07-10-16Holding(s) in CompanyRNS
04-10-16Result of AGMRNS
30-09-16ANGLE notes research results in Clinical ChemistryStockMarketWire
30-09-16Research published in Clinical ChemistryRNS
19-09-16Issue of EquityRNS
09-09-16Annual Report and Accounts and Notice of AGMRNS
04-08-16MD Anderson Cancer Center poster presentationRNS
02-08-16Edison issues ADR update on AngleRNS
28-07-16ANGLE revenue upStockMarketWire
28-07-16Use of Parsortix in GANNET53 drug trialRNS
28-07-16Preliminary ResultsRNS
27-07-16ANGLE initiates ovarian cancer study in the USStockMarketWire
27-07-16Initiation of 200 patient US ovarian cancer studyRNS
19-07-16ANGLE initiates European ovarian cancer study StockMarketWire
19-07-16Initiation of European ovarian cancer studyRNS
15-07-16Notice of ResultsRNS
15-07-16Parsortix gaining traction at EACR ConferenceRNS
01-06-16Holding(s) in CompanyRNS
31-05-16Holding(s) in CompanyRNS
27-05-16Edison research update on AngleStockMarketWire
27-05-16Edison issues research update on AngleRNS
25-05-16ANGLE wins contract with Cancer Research UKStockMarketWire
25-05-16Cancer Research UK ContractRNS

RSS feeds

  • Editorial news feed for LSE:AGL Editorial
  • Regulatory news feed for LSE:AGL Regulatory